Ali Aliabadi

9PUBLICATIONS
9CO-AUTHORS
Cancer diagnosisMolecular targetsChemical and thermal processes in energy and combustionGlycoconjugatesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
A New Survey about Dual-Acting PARP/COX-2 Inhibitors as Cancer Chemopreventive Agents.

|Oct 17, 2025
Evaluation of Anticarcinogenic and Cytotoxic Effects of COX-2 Specific Inhibitors on an Animal Model of Hepatocellular Carcinoma Using Isolated Mitochondria.

Alireza Mahmudi, Enayatollah Seydi, Nahid Ahmadi

|Jan 20, 2025
Dual COX-2/TNF-α Inhibitors as Promising Anti-inflammatory and Cancer Chemopreventive Agents: A Review.

Mobina Tajdari, Amirreza Peyrovinasab, Maryam Bayanati

|Dec 20, 2023
Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway.

Havva Afshari, Shokoofe Noori, Afshin Zarghi

|Dec 20, 2023
Co-treatment of Naringenin and Ketoprofen-RGD Suppresses Cell Proliferation via Calmodulin/PDE/cAMP/PKA Axis Pathway in Leukemia and Ovarian Cancer Cells.

Havva Afshari, Shokoofe Noori, Bahareh Shokri

|Mar 10, 2023
Application of SPRA Technology for Delivery of Erythropoietin: Stability Evaluation of Conjugated Erythropoietin with Adamantane and in SPRA Inclusion Complex.

Bahareh Alizadeh, Afshin Zarghi, Arash Mahboubi

Pageof 2